G
Genor BioPharma Co.
Sustainability Report and Carbon Intensity Rankings
Is Genor BioPharma Co. doing their part?
Their DitchCarbon score is 32
Genor BioPharma Co. has a DitchCarbon Score of 32 out of 100, indicating a lower performance in sustainability measures. This score suggests that the company has a relatively high carbon intensity compared to more sustainable peers. Efforts to reduce emissions and improve sustainability practices are needed to increase their DitchCarbon Score.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Genor BioPharma Co. operates in the health and social services industry, which has a carbon intensity ranking of low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Genor BioPharma Co., located in China, operates in a region with a certain carbon intensity rating. The sustainability of the company’s operations is influenced by China’s overall carbon footprint, which affects the environmental impact of their business activities.
Unlock 30+ emissions data points on Genor BioPharma Co.
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Genor BioPharma Co.
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
9.56%
...this company is doing 9.56% worse in emissions than the industry average.
Genor BioPharma Co., Ltd., founded in 2008, is situated in Shanghai, China, at 936 Zhangheng Road. Operating within the biotechnology sector, the company specializes in health and social services. They are known for their innovative approach to developing and providing biopharmaceutical products and therapies.
emission intelligence's platform recommendations for Genor BioPharma Co.
Genor BioPharma Co. should consider the implementation of green procurement policies to source low-carbon energy and services, which could potentially reduce their emissions by 30%.
Bad news, Genor BioPharma has yet to commit to SBTi.
Genor BioPharma Co. has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining its goals for reducing greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.